Home » Topics » BioWorld Science

BioWorld Science
RSS

Astrocyte-driven inflammation is depression biomarker, target

Sep. 27, 2018

CHK1 inhibition improves established PAH in vivo

Sep. 26, 2018

JCR's agalsidase beta biosimilar approved in Japan for Fabry disease

Sep. 26, 2018

Japanese approval for Oravi for oropharyngeal candidiasis

Sep. 26, 2018

Targeting hepatic OGA ameliorates hyperammonemia researchers find

Sep. 26, 2018

European Commission approves pegfilgrastim biosimilar Udenyca

Sep. 26, 2018

IntelGenx initiates phase IIa study of montelukast buccal film for Alzheimer's

Sep. 26, 2018

DSMB clears continuation of phase I/IIa study of VBI-1902 in recurrent GBM

Sep. 26, 2018

Santen and PeptiDream enter ophthalmic multitarget discovery and development agreement

Sep. 26, 2018

Achillion Pharmaceuticals divulges complement factor D inhibitors

Sep. 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...